APA (7th ed.) Citation

E, G., M, V., L, G., A, R., M, M., A, P., . . . J, V. (2026). Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 201, 119741. https://doi.org/10.1016/j.biopha.2026.119741

Chicago Style (17th ed.) Citation

E, Gonzalez-Sanchez, et al. "Inhibition of the ZEB1-BCL2 Axis in Cancer-associated Fibroblasts as a Strategy to Improve Chemotherapy Response in Intrahepatic Cholangiocarcinoma." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 201 (2026): 119741. https://doi.org/10.1016/j.biopha.2026.119741.

MLA (9th ed.) Citation

E, Gonzalez-Sanchez, et al. "Inhibition of the ZEB1-BCL2 Axis in Cancer-associated Fibroblasts as a Strategy to Improve Chemotherapy Response in Intrahepatic Cholangiocarcinoma." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 201, 2026, p. 119741, https://doi.org/10.1016/j.biopha.2026.119741.